TITLE

Continuous Infusion of Amphotericin B Deoxycholate: A Cost-Effective Gold Standard for Therapy of Invasive Fungal Infections?

AUTHOR(S)
Schneemann, Markus; Bachli, Esther B.
PUB. DATE
January 2004
SOURCE
Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p303
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Comments on the cost-effectiveness of continuous infusion of amphotericin B deoxycholate (AmBD) for therapy of invasive fungal infections. Number of patients who develop acute renal failure while receiving therapy with AmBD; Combination of antifungal treatment with daily monitoring and aggressive correction of electrolyte levels and hydration; Expensiveness of lipid formulations of amphotericin B.
ACCESSION #
12083446

 

Related Articles

  • 400. Consider alternative agents for fungal infections in patients at high risk of acute renal failure. Bates, D.W.; Su, L.; Yu, D.T. // Kidney;May/Jun2002, Vol. 11 Issue 3, p133 

    Deals with a study which examined the correlates of acute renal failure in patients receiving parenteral amphotericin B. Methodology; Results; Conclusion.

  • Correlates of acute renal failure in patients receiving parenteral amphotericin B. Bates, David W.; Su, Ling; Yu, Donghui T.; Chertow, Glenn M.; Seger, Diane L.; Gomes, Daniel R.J.; Platt, Richard // Kidney International;Oct2001, Vol. 60 Issue 4, p1452 

    Correlates of acute renal failure in patients receiving parenteral amphotericin B. Background. While parenteral amphotericin B is an effective therapy for serious fungal infections, it frequently causes acute renal failure (ARF). This study identified correlates of ARF in amphotericin B therapy...

  • Amphotericin-B.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p30 

    The article is a case report of a 32-year-old female with acute renal failure developed while being treated for amphotericin-B.

  • Amphotericin B/cefepime/fluconazole/tretinoin.  // Reactions Weekly;3/3/2012, Issue 1391, p8 

    The article describes the case of a 47-year-old woman who developed acute renal failure while under cefepime, tretinoin, fluconazole and amphotericin B treatment regimen for acute promyelocytic leukaemia.

  • Amphotericin B/itraconazole.  // Reactions Weekly;2/11/2012, Issue 1388, p6 

    The article describes the case of a 32-year-old man who developed acute renal failure and hypersensitivity while receiving amphotericin B and itraconazole for chronic pulmonary blastomycosis.

  • Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections: Results of the Collaborative Exchange of Antifungal Research (CLEAR), an Industry-Supported Patient Registry. Pappas, Peter G. // Clinical Infectious Diseases;5/1/2005 Supplement, Vol. 40, pS379 

    This article focuses on the use of amphotericin B lipid complex (ABLC) for the treatment of invasive fungal infections. ABLC is a composition of amphotericin B and 2 phospholipids, dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol, in a 1:1 drug-to-lipid molar ratio. ABLC was...

  • Reply. Ostrosky-Zeichner, Luis; Marr, Kieren A.; Rex, John H.; Cohen, Stuart H. // Clinical Infectious Diseases;1/15/2004, Vol. 38 Issue 2, p306 

    Comments on the use of lipid formulations of amphotericin B in treating invasive fungal infections. Possibility of using continuous infusions of amphotericin B deoxycholate (AmBD); Limited comparative data supporting the efficacy of continuously infused AmBD; Link of short- and long-term...

  • Amphotericin B.  // Reactions Weekly;4/3/2004, Issue 995, p6 

    Presents a reference to case reports on acute renal failure induced by amphotericin B in the treatment of invasive aspergillesis in patients with acute myeloblastic leukemia.

  • Amphotericin B liposomal.  // Reactions Weekly;7/1/2013, Issue 1459, p7 

    The article presents a case study of a 41-year-old woman with acute renal failure, which developed after receiving amphotericin B liposomal for Cryptococcal osteomyelitis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics